Other Assets

6 Months Ended

Sep. 30, 2021

Other Assets [Abstract]

Other Assets

Note 10. Other Assets

The components of other assets are as follows:

	September 30, 2021		March 31, 2021
	(in thousands)
Investment in Shockwave Medical	$	61,096	$	38,655
Other investments (Note 6)		55,418		62,995
Operating lease right of use asset (Note 11)		5,099		6,109
Other intangible assets and other assets		6,568		5,323
Total other assets	$	128,181	$	113,082

Investment in Shockwave Medical

During the three months ended September 30, 2021 and 2020, the Company recorded gains of $4.8 million and $10.8 million, respectively in other income. During the six months ended September 30, 2021 and 2020, the Company recorded gains of $22.4 million and $34.7 million, respectively in other income. During the six months ended September 30, 2020, the Company sold approximately 1.4 million of its shares in Shockwave Medical for cash proceeds of $67.9 million and recognized a gain of $47.3 million.               

Other Intangible Assets and Other Assets

The Company’s other intangible assets and other assets is comprised primarily of license manufacturing rights to certain technology from third parties and other long-term assets such as from third parties and other long-term assets such as prepayments related to the Company’s clinical trial activities.